Submission for EU approval of a triple-medicine combination therapy for hypertension in a single pill containing Tekturna/Rasilez, amlodipine and hydrochlorothiazide was achieved in May, following the US submission in the first quarter.
l’hypertension en un comprimé unique associant Rasilez/Tekturna, amlodipine et hydrochlorothiazide, dans la foulée d’un dépôt similaire au premier trimestre aux Etats-Unis.
